Is there a generic for Otrexup?

Methotrexate is the generic name for the trade drug names Otrexup™, Rasuvo®, Rheumatrex® and Trexall™. MTX, Amethopterin, and Methotrexate Sodium are other names for Methotrexate.

How much does Otrexup cost?

The cost for Otrexup subcutaneous solution (10 mg/0.4 mL) is around $688 for a supply of 1.6 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans. Otrexup is available as a brand name drug only, a generic version is not yet available.

Where do you inject Otrexup?

Otrexup should be injected in the stomach (abdomen) or thigh.

What is the trade name of methotrexate?

Mexate – Zydus (Synovia) [Methotrexate]

Is Methotrexate a cytotoxic drug?

Methotrexate is a folic acid antagonist and is classified as an antimetabolite cytotoxic agent.

Is Methotrexate a chemo drug?

Methotrexate is a chemotherapy drug used to treat many different cancers.

Can methotrexate cause you to gain weight?

Methotrexate was shown to cause a modest amount of weight gain over 6 months, in a study measuring weight changes in people with rheumatoid arthritis. The patients who were most likely to gain weight when starting methotrexate, were patients who had recently lost weight due to rheumatoid arthritis.

What is Otrexup used for?

Otrexup (methotrexate) Injection is a folate analog metabolic inhibitor used in adults to manage severe, active rheumatoid arthritis (RA) (ACR criteria), or children with active polyarticular juvenile idiopathic arthritis (pJIA), who have had an insufficient therapeutic response to, or are intolerant of, an adequate …

What is the difference between Rasuvo and Otrexup?

Rasuvo is a single-dose auto-injection device that comes in 10 different doses of methotrexate: 7.5, 10, 12.5, 15, 17.5, 20, 22.5, 27.5, and 30 mg. Otrexup is available in doses of 10, 15, 20 or 25 mg per 4 mL.

Does methotrexate help with Covid 19?

Patients Taking Methotrexate Respond Less Well to COVID-19 Vaccine | NYU Langone News. One-quarter of people who take the drug methotrexate for common immune system disorders—from rheumatoid arthritis to multiple sclerosis—mount a weaker immune response to a coronavirus disease (COVID-19) vaccine, a new study shows.